| James P Konerman, MD | |
|
1500 James Simpson Jr Way, Covington, KY 41011 | |
| (859) 912-7211 | |
| (859) 655-8981 |
| Full Name | James P Konerman |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 40 Years |
| Location | 1500 James Simpson Jr Way, Covington, Kentucky |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1588666978 | NPI | - | NPPES |
| 000000536346 | Other | ANTHEM | |
| 0659256 | Medicaid | OH | |
| 158866978 | Other | MEDICAL MUTUAL | |
| 2565399 | Medicaid | OH | |
| 4065714 | Other | AETNA | |
| P00419304 | Other | RAILROAD MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 41236 (Kentucky) | Secondary |
| 208M00000X | Hospitalist | 35.052189 (Ohio) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Bethesda North | Cincinnati, OH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Trihealth G Llc | 0749222651 | 253 |
News Archive
Although congressional Democrats and President Barack Obama hope to make electoral hay out of the GOP budget's Medicare revamp, GOP Republican presidential hopeful Mitt Romney is proving to have appeal. During the primary thus far, Romney has fared well with older voters in swing states.
Vertex Pharmaceuticals Incorporated today announced that it has awarded 16 grants totaling approximately $1.5 million to a variety of academic, patient and community groups as part of the Vertex Hep-C Circle of Care program, a pilot competitive grants program designed to foster innovative approaches to patient care and support people living with chronic hepatitis C.
ViewRay, Inc. announced today that the company has received regulatory approval from the Ministry of Food and Drug Safety (MFDS) – formerly known as the Korean Food and Drug Administration – to sell its ViewRay system in Korea. On October 13, 2015, the first patient treatments commenced less than four weeks after the system completed installation at Seoul National University Hospital, a leading healthcare facility in Korea.
Intensive medical therapy, including aggressive control of blood pressure and cholesterol levels, for patients with asymptomatic plaque buildup in their carotid arteries (which supply blood to the brain) appears to be associated with reduced rates of cardiovascular events and reduced risk of microemboli (microscopic-sized blood clots) in the brain arteries, according to a report posted online today that will appear in the February 2010 print issue of Archives of Neurology, one of the JAMA/Archives journals.
Depomed, Inc. announced today that it has received a Notice of Allowance from the U.S. Patent and Trademark Office for a U.S. patent application (No. 12/239,591) directed to pharmaceutical dosage forms that deliver the compound gabapentin via Depomed's proprietary Acuform® gastric retentive drug delivery technology.
› Verified 3 days ago
| Entity Name | Bethesda Family Practice Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1124061494 PECOS PAC ID: 7012905292 Enrollment ID: O20040505000929 |
News Archive
Although congressional Democrats and President Barack Obama hope to make electoral hay out of the GOP budget's Medicare revamp, GOP Republican presidential hopeful Mitt Romney is proving to have appeal. During the primary thus far, Romney has fared well with older voters in swing states.
Vertex Pharmaceuticals Incorporated today announced that it has awarded 16 grants totaling approximately $1.5 million to a variety of academic, patient and community groups as part of the Vertex Hep-C Circle of Care program, a pilot competitive grants program designed to foster innovative approaches to patient care and support people living with chronic hepatitis C.
ViewRay, Inc. announced today that the company has received regulatory approval from the Ministry of Food and Drug Safety (MFDS) – formerly known as the Korean Food and Drug Administration – to sell its ViewRay system in Korea. On October 13, 2015, the first patient treatments commenced less than four weeks after the system completed installation at Seoul National University Hospital, a leading healthcare facility in Korea.
Intensive medical therapy, including aggressive control of blood pressure and cholesterol levels, for patients with asymptomatic plaque buildup in their carotid arteries (which supply blood to the brain) appears to be associated with reduced rates of cardiovascular events and reduced risk of microemboli (microscopic-sized blood clots) in the brain arteries, according to a report posted online today that will appear in the February 2010 print issue of Archives of Neurology, one of the JAMA/Archives journals.
Depomed, Inc. announced today that it has received a Notice of Allowance from the U.S. Patent and Trademark Office for a U.S. patent application (No. 12/239,591) directed to pharmaceutical dosage forms that deliver the compound gabapentin via Depomed's proprietary Acuform® gastric retentive drug delivery technology.
› Verified 3 days ago
| Entity Name | Trihealth G Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1295862944 PECOS PAC ID: 0749222651 Enrollment ID: O20050601000358 |
News Archive
Although congressional Democrats and President Barack Obama hope to make electoral hay out of the GOP budget's Medicare revamp, GOP Republican presidential hopeful Mitt Romney is proving to have appeal. During the primary thus far, Romney has fared well with older voters in swing states.
Vertex Pharmaceuticals Incorporated today announced that it has awarded 16 grants totaling approximately $1.5 million to a variety of academic, patient and community groups as part of the Vertex Hep-C Circle of Care program, a pilot competitive grants program designed to foster innovative approaches to patient care and support people living with chronic hepatitis C.
ViewRay, Inc. announced today that the company has received regulatory approval from the Ministry of Food and Drug Safety (MFDS) – formerly known as the Korean Food and Drug Administration – to sell its ViewRay system in Korea. On October 13, 2015, the first patient treatments commenced less than four weeks after the system completed installation at Seoul National University Hospital, a leading healthcare facility in Korea.
Intensive medical therapy, including aggressive control of blood pressure and cholesterol levels, for patients with asymptomatic plaque buildup in their carotid arteries (which supply blood to the brain) appears to be associated with reduced rates of cardiovascular events and reduced risk of microemboli (microscopic-sized blood clots) in the brain arteries, according to a report posted online today that will appear in the February 2010 print issue of Archives of Neurology, one of the JAMA/Archives journals.
Depomed, Inc. announced today that it has received a Notice of Allowance from the U.S. Patent and Trademark Office for a U.S. patent application (No. 12/239,591) directed to pharmaceutical dosage forms that deliver the compound gabapentin via Depomed's proprietary Acuform® gastric retentive drug delivery technology.
› Verified 3 days ago
| Entity Name | Trihealth H Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1811215742 PECOS PAC ID: 1850570458 Enrollment ID: O20110128000356 |
News Archive
Although congressional Democrats and President Barack Obama hope to make electoral hay out of the GOP budget's Medicare revamp, GOP Republican presidential hopeful Mitt Romney is proving to have appeal. During the primary thus far, Romney has fared well with older voters in swing states.
Vertex Pharmaceuticals Incorporated today announced that it has awarded 16 grants totaling approximately $1.5 million to a variety of academic, patient and community groups as part of the Vertex Hep-C Circle of Care program, a pilot competitive grants program designed to foster innovative approaches to patient care and support people living with chronic hepatitis C.
ViewRay, Inc. announced today that the company has received regulatory approval from the Ministry of Food and Drug Safety (MFDS) – formerly known as the Korean Food and Drug Administration – to sell its ViewRay system in Korea. On October 13, 2015, the first patient treatments commenced less than four weeks after the system completed installation at Seoul National University Hospital, a leading healthcare facility in Korea.
Intensive medical therapy, including aggressive control of blood pressure and cholesterol levels, for patients with asymptomatic plaque buildup in their carotid arteries (which supply blood to the brain) appears to be associated with reduced rates of cardiovascular events and reduced risk of microemboli (microscopic-sized blood clots) in the brain arteries, according to a report posted online today that will appear in the February 2010 print issue of Archives of Neurology, one of the JAMA/Archives journals.
Depomed, Inc. announced today that it has received a Notice of Allowance from the U.S. Patent and Trademark Office for a U.S. patent application (No. 12/239,591) directed to pharmaceutical dosage forms that deliver the compound gabapentin via Depomed's proprietary Acuform® gastric retentive drug delivery technology.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| James P Konerman, MD Po Box 635283, Cincinnati, OH 45263-5283 Ph: (859) 912-7211 | James P Konerman, MD 1500 James Simpson Jr Way, Covington, KY 41011 Ph: (859) 912-7211 |
News Archive
Although congressional Democrats and President Barack Obama hope to make electoral hay out of the GOP budget's Medicare revamp, GOP Republican presidential hopeful Mitt Romney is proving to have appeal. During the primary thus far, Romney has fared well with older voters in swing states.
Vertex Pharmaceuticals Incorporated today announced that it has awarded 16 grants totaling approximately $1.5 million to a variety of academic, patient and community groups as part of the Vertex Hep-C Circle of Care program, a pilot competitive grants program designed to foster innovative approaches to patient care and support people living with chronic hepatitis C.
ViewRay, Inc. announced today that the company has received regulatory approval from the Ministry of Food and Drug Safety (MFDS) – formerly known as the Korean Food and Drug Administration – to sell its ViewRay system in Korea. On October 13, 2015, the first patient treatments commenced less than four weeks after the system completed installation at Seoul National University Hospital, a leading healthcare facility in Korea.
Intensive medical therapy, including aggressive control of blood pressure and cholesterol levels, for patients with asymptomatic plaque buildup in their carotid arteries (which supply blood to the brain) appears to be associated with reduced rates of cardiovascular events and reduced risk of microemboli (microscopic-sized blood clots) in the brain arteries, according to a report posted online today that will appear in the February 2010 print issue of Archives of Neurology, one of the JAMA/Archives journals.
Depomed, Inc. announced today that it has received a Notice of Allowance from the U.S. Patent and Trademark Office for a U.S. patent application (No. 12/239,591) directed to pharmaceutical dosage forms that deliver the compound gabapentin via Depomed's proprietary Acuform® gastric retentive drug delivery technology.
› Verified 3 days ago
Wael E Eid, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1500 James Simpson Jr Way, Suite 301, Covington, KY 41011 Phone: 859-655-8910 Fax: 859-655-8911 |